Need all Congresses? Press Enter for expanded federal results.
HRES 95
114th Congress • 2015-2017 (Ended)

Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.


HRES 95
Feb 5, 2015
Referred to the Subcommittee on Health.